铜绿假单胞菌
囊性纤维化
抗生素
荟萃分析
微生物学
医学
内科学
生物
遗传学
细菌
作者
Ali Rastegar-Kashkouli,Azad Khaledi,Farzaneh Moammer,Mohammad Ghenaat Pisheh Sanani,Mohammad Mahdi Heidari,Aynaz Foroughi Eghbal
标识
DOI:10.5152/eurasianjmed.2024.23302
摘要
This study aimed to conduct a retrospective Middle East systematic review and meta-analysis on the prevalence and antibiotic susceptibility pattern for this microorganism isolated from cystic fibrosis patients. We searched MEDLINE, the Cochrane Library, SCOPUS, and Web of Science (ISI) to identify studies that reported the prevalence of Pseudomonas aeruginosa isolated from cystic fibrosis (CF) patients, and antibiotic resistance patterns. To assess the quality of publications was used of a checklist provided by the Joanna Briggs Institute. Finally, the data was analyzed by comprehensive meta-analysis software. The studied populations comprised children and young, and adult CF patients. Patients were aged between 3 months-65 years. A higher percentage of CF patients were males. Pseudomonas aeruginosa frequency varied between 5.9 and 76.2% in the studies included. The combined prevalence of P. aeruginosa was reported 34.3%. The lowest level resistance of P. aeruginosa was toward colistin (0%-13.3%) and ticarcillin (3.9%-24%). Our study showed the prevalence of P. aeruginosa and antibiotic resistance are almost high, while colistin and ticarcillin are the best antibiotics to decrease postantibiotic efects (PAEs) in CF patients from the Middle East. Therefore, physicians should pay more attention to therapeutic protocols to prevent further resistance. Cite this article as: Rastegar-Kashkouli A, Khaledi A, Moammer F, Ghenaatpisheh Sanani M, Heidari MM, Foroughi Eghbal A. Systematic review and meta-analysis on the prevalence and antibiotic susceptibility pattern in pseudomonas aeruginosa isolated from cystic fibrosis patients. Eurasian J Med. 2024;56(3):189-198.
科研通智能强力驱动
Strongly Powered by AbleSci AI